Skip to main navigation Skip to search Skip to main content

Correlation of estrogen receptor alpha and bets (ER alpha and ER beta) gene and protein expression in breast cancer cell lines and tissue.

Project: RESEARCH PROJECT

Project Details

Description

Background: Human breast cancer cell (BCC) lines are used extensively in biomedical research and are classified as estrogen receptor (ER)-positive or ER-negative. We used flow cytometry (FCM), reverse transcription-polymerase chain reaction (RT-PCR) and Western blotting (WB) to assess ER expression in human BCC lines reported as being ER-positive (MCF7, T-47D, ZR-75-1) or ER-negative (MDA-MB-231, SK-BR-3, MDA-MB-453, HCC1954) to determine the validity of this classification. Materials and Methods: ER was assessed in permeablized, fixed cells by FCM using two monoclonal anti-ERa antibodies and a polyclonal anti-ERβ antibody, in parallel with RT-PCR and WB. Results: All of the cell lines expressed ERa and ERβ. Indirect immunofluorescence indicated that it was membrane and cytoplasmic ER that was being detected by FCM. Down-regulation by fulvestrant confirmed it was ER. Conclusion: These results demonstrate the importance of reassessing the ER status of human BCC lines that are used widely in biomedical research.

StatusFinished
Effective start/end date9/07/03 → 8/07/07

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Estrogen receptor
  • Breast cancer

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.